Results 111 to 120 of about 11,847 (121)

[Impact of a primary care pharmacy unit on the optimization of pharmacological treatment of type 2 diabetic patients]. [PDF]

Aten Primaria
Canadell-Vilarrasa L, Palanques-Pastor T, Campabadal-Prats C, Salom-Garrigues C, Conde-Giner S, Bejarano-Romero F.   +5 more
europepmc   +1 more source

Inflammatory markers associated with albuminuria and early atherosclerosis in type 2 diabetic kidney disease: a cross-sectional study. [PDF]

Front Endocrinol (Lausanne)
González-Luis A, Siverio-Morales O, Hernández-Carballo C, Mora-Fernández C, Martín-Núñez E, Reyes-Carrión A, Carlos-Monzón JD, Navarro-González JF, Donate-Correa J.   +8 more
europepmc   +1 more source

Novel biomarkers for CKD risk stratification: a literature review. [PDF]

J Bras Nefrol
Khan S, Zobairi A, Rehan E, Mohammed AH.
europepmc   +1 more source

[Diabetes mellitus: complications associated with time since diagnosis, health insurance, use of health services, and medication use, Brazilian National Health Survey 2019]. [PDF]

Cad Saude Publica
Leitão VBG, Andrade LG, Bacurau AGM, Assumpção D, Francisco PMSB.   +4 more
europepmc   +1 more source

Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial. [PDF]

Cardiovasc Diabetol
Donate-Correa J, Ferri CM, Mora-Fernández C, Pérez-Delgado N, González-Luis A, Navarro-González JF.   +5 more
europepmc   +1 more source

Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists. [PDF]

Int J Mol Sci
Llinares-Arvelo V, Martínez-Alberto CE, González-Luis A, Macía-Heras M, Siverio-Morales O, Navarro-González JF, Donate-Correa J.   +6 more
europepmc   +1 more source

SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease. [PDF]

J Bras Nefrol
Machado Júnior PAB, Lass A, Pilger BI, Fornazari R, Moraes TP, Pinho RA.   +5 more
europepmc   +1 more source

FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease. [PDF]

Int J Mol Sci
Donate-Correa J, Martín-Núñez E, Hernández-Carballo C, González-Luis A, Mora-Fernández C, Martín-Olivera A, Rodríguez-Ramos S, Cerro-López P, López-Castillo Á, Delgado-Molinos A, López-Tarruella VC, Navarro-González JF.   +11 more
europepmc   +1 more source

[Impact of educational intervention in a population with type 2 diabetes mellitus] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Tafurt Cardona Y, Ramón Collazos RA, Murillo Cumber CA, Ortiz Tique JP, Mendoza Perez P, Peralta-Pineda E.   +5 more
europepmc   +1 more source